Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Singleton, PhD
Laboratory of Neurogenetics; National Institute on Aging NIH
Study Director - Arthur W. Toga, PhD
University of California, Los Angeles
Study Director - Christopher Coffey, PhD
Clinical Trials Statistical and Data Management Center, University of Iowa
Study Director - John P Seibyl, MD
Institute for Neurodegenerative Disorders
Study Director - John Q. Trojanowski, MD, PhD
University of Pennsylvania
Study Director - Kenneth L Marek, MD
Institute for Neurodegenerative Disorders
Study Chair - Tatiana Froud, PhD
Indiana University
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Macquarie University
Sydney, Australia
- Innsbruck Medical University
Innsbruck, Austria
- Hospital Pitie-Salpetriere
Paris, France
- Paracelsus-Elena Klinik
Kassel, Germany
- University of Tuebingen
Tübingen, Germany
- Foundation for Biomedical Research of the Academy of Athens
Athens, Greece
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
- Universita Federico Ii
Naples, Italy
- University of Salerno
Salerno, Italy
- St. Olavs Hospital
Trondheim, Norway
- Hospital Clinic de Barcelona
Barcelona, Spain
- Hospital Donostia
Donostia / San Sebastian, Spain
- Imperial College London
London, United Kingdom
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Banner Research Institute
Sun City, Arizona, United States
- University of California San Diego
La Jolla, California, United States
- University of California, San Francisco
San Francisco, California, United States
- the Parkinson'S Institute
Sunnyvale, California, United States
- Institute for Neurodegenerative Disorders
New Haven, Connecticut, United States
- Parkinson'S Disease& Movement Disorder Center of Boca Raton
Boca Raton, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- John Hopkins University
Baltimore, Maryland, United States
- Boston University
Boston, Massachusetts, United States
- Beth Israel Medical Center
New York, New York, United States
- Columbia University Medical Center
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- University of Cincinnati/cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Oregon Health &science University
Portland, Oregon, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Baylor College of Medicine
Houston, Texas, United States
- Univ of Washington and Va Puget Sound Health Care System
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 30 Jun 2020
- Completion
- 30 Jun 2020
- Last update posted
- 14 Nov 2023
- Registered enrollment
- 952
- Registry id
- NCT01141023
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.